Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$209.01 - $232.56 $154,876 - $172,326
741 Added 0.8%
93,612 $20.5 Million
Q4 2023

Feb 13, 2024

BUY
$197.69 - $227.29 $87,972 - $101,144
445 Added 0.48%
92,871 $21.1 Million
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $135,909 - $149,869
676 Added 0.74%
92,426 $18.6 Million
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $56,373 - $64,193
-266 Reduced 0.29%
91,750 $22.1 Million
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $1.83 Million - $2.21 Million
-8,572 Reduced 8.52%
92,016 $21.1 Million
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $432,701 - $528,812
-2,124 Reduced 2.07%
100,588 $23.7 Million
Q3 2022

Nov 10, 2022

BUY
$204.81 - $262.19 $378,898 - $485,051
1,850 Added 1.83%
102,712 $21 Million
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $88,751 - $115,316
-415 Reduced 0.41%
100,862 $23.6 Million
Q1 2022

May 16, 2022

SELL
$259.82 - $298.18 $528,993 - $607,094
-2,036 Reduced 1.97%
101,277 $26.7 Million
Q4 2021

Feb 15, 2022

SELL
$271.6 - $314.21 $294,957 - $341,232
-1,086 Reduced 1.04%
103,313 $32.5 Million
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $398,763 - $447,401
-1,451 Reduced 1.37%
104,399 $29.4 Million
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $519,104 - $573,246
-2,061 Reduced 1.91%
105,850 $29.2 Million
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $144,850 - $180,306
707 Added 0.66%
107,911 $27.5 Million
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $203,731 - $233,717
1,090 Added 1.03%
107,204 $21.8 Million
Q3 2020

Nov 16, 2020

BUY
$167.03 - $201.3 $1.35 Million - $1.62 Million
8,053 Added 8.21%
106,114 $20 Million
Q2 2020

Aug 14, 2020

BUY
$113.31 - $182.44 $27,760 - $44,697
245 Added 0.25%
98,061 $16.3 Million
Q1 2020

May 15, 2020

SELL
$104.32 - $195.28 $23,367 - $43,742
-224 Reduced 0.23%
97,816 $12.4 Million
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $5,394 - $5,729
33 Added 0.03%
98,040 $16.6 Million
Q3 2019

Nov 13, 2019

BUY
$159.77 - $178.1 $334,238 - $372,585
2,092 Added 2.18%
98,007 $16.5 Million
Q2 2019

Aug 15, 2019

BUY
$144.16 - $172.9 $157,999 - $189,498
1,096 Added 1.16%
95,915 $16.6 Million
Q1 2019

May 15, 2019

SELL
$123.7 - $156.3 $65,808 - $83,151
-532 Reduced 0.56%
94,819 $14.5 Million
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $285,135 - $410,852
-2,360 Reduced 2.42%
95,351 $12 Million
Q3 2018

Nov 14, 2018

BUY
$167.67 - $188.27 $113,847 - $127,835
679 Added 0.7%
97,711 $17 Million
Q2 2018

Aug 09, 2018

BUY
$160.33 - $189.41 $386,395 - $456,478
2,410 Added 2.55%
97,032 $17.4 Million
Q1 2018

May 10, 2018

BUY
$161.53 - $178.11 $458,099 - $505,119
2,836 Added 3.09%
94,622 $0
Q4 2017

Feb 14, 2018

BUY
$147.99 - $163.95 $70,887 - $78,532
479 Added 0.52%
91,786 $0
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $211,500 - $227,192
1,415 Added 1.57%
91,307 $0
Q2 2017

Aug 14, 2017

BUY
N/A
89,892
89,892 $0

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.